New scleroderma registry aims to unlock secrets of rare disease

NCT ID NCT01656447

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This registry is collecting medical information and biological samples from 300 adults with scleroderma at a single hospital. The goal is to better understand the disease's features, genetics, and progression. While this study does not test any treatment, the data gathered could help scientists develop new therapies in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this registry could help researchers uncover the causes of scleroderma and point toward potential treatments for this currently untreatable condition.

What could go wrong

This is an observational registry, not a treatment trial. It collects information only and does not test any therapy, so it may not directly lead to a cure or new drug.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCLERODERMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diffuse scleroderma scleroderma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital for Special Surgery

    RECRUITING

    New York, New York, 10021, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact